Arcus Biosciences Inc (RCUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 26,000 | 48,000 | 39,000 | 145,000 | 31,000 |
| Gross Profit | 26,000 | 48,000 | 39,000 | 145,000 | 31,000 |
| Operating Expenses | 129,000 | 153,000 | 145,000 | 161,000 | 122,000 |
| Operating Income | -103,000 | -105,000 | -106,000 | -16,000 | -91,000 |
| Interest Expense | 2,000 | 1,000 | 0 | 1,000 | 1,000 |
| Other Income | 12,000 | 14,000 | 13,000 | 13,000 | 12,000 |
| Pre-tax Income | -93,000 | -92,000 | -93,000 | -4,000 | -80,000 |
| Income Tax | N/A | N/A | N/A | N/A | 1,000 |
| Net Income Continuous | -94,000 | -92,000 | -93,000 | -4,000 | -81,000 |
| Net Income | $-94,000 | $-92,000 | $-93,000 | $-4,000 | $-81,000 |
| EPS Basic Total Ops | -1.07 | -1.00 | -1.02 | -0.05 | -1.08 |
| EPS Basic Continuous Ops | -1.07 | -1.01 | -1.02 | -0.05 | -1.08 |
| EPS Diluted Total Ops | -1.07 | -1.00 | -1.02 | -0.05 | -1.08 |
| EPS Diluted Continuous Ops | -1.07 | -1.01 | -1.02 | -0.05 | -1.08 |
| EPS Diluted Before Non-Recurring Items | -1.03 | -1.00 | -1.02 | N/A | N/A |
| EBITDA(a) | $-106,000 | $-109,000 | $-111,000 | $-19,000 | $-94,000 |